Home
About us
Our management
Corporate Executive Team

Corporate Executive Team

Andrew Witty - Chief Executive Officer

Andrew Witty became CEO in May 2008 after joining the Board in January 2008.

Find out more about Andrew Witty

Simon Bicknell - Senior Vice President, Company Secretary & Compliance Officer

Simon Bicknell was appointed Company Secretary for GSK in 2000, and Compliance Officer in 2006. He joined the CET in May 2008.

Find out more about Simon Bicknell

John Clarke - President, Consumer Healthcare

John Clarke assumed the role of President, Consumer Healthcare, GlaxoSmithKline in January 2006.

Find out more about John Clarke

Marc Dunoyer - President, Asia Pacific/Japan

Marc Dunoyer was made responsible for the new Asia Pacific region, encompassing all the countries in this area, including Japan and Australia in May 2008.

Find out more about Marc Dunoyer

Eddie Gray - President, Pharmaceuticals Europe

Eddie Gray became President, Pharmaceuticals Europe for GlaxoSmithKline in January 2008.

Find out more about Eddie Gray

Julian Heslop - Chief Financial Officer

Julian Heslop assumed the role of Chief Financial Officer for GlaxoSmithKline in April 2005.

Find out more about Julian Heslop

Abbas Hussain - President, Emerging Markets

Abbas Hussain assumed the role of President, Emerging Markets, GlaxoSmithKline in June 2008.

Find out more about Abbas Hussain

Duncan Learmouth - Senior Vice President, Corporate Communications and Community Partnerships

Duncan Learmouth was appointed Senior Vice President, Corporate Communications and Community Partnerships for GlaxoSmithKline in July 2006.

Find out more about Duncan Learmouth

Bill Louv - Chief Information Officer

Bill Louv assumed responsibility for information technology, which enables key business processes across the company, in 2007.

Find out more about Bill Louv

Dan Phelan - Chief of Staff

Dan Phelan became Chief of Staff with primary responsibility for leading the critical support functions for GSK in May 2008.

Find out more about Dan Phelan

David Pulman - President, Global Manufacturing and Supply

David Pulman took up the position of President, Global Manufacturing and Supply (GMS), GlaxoSmithKline in December 2002.

Find out more about David Pulman

David Redfern - Chief Strategy Officer

David Redfern was appointed Chief Strategy Officer in May 2008.

Find out more about David Redfern

Moncef Slaoui - Chairman, Research & Development

Moncef Slaoui assumed the role of Chairman, Research & Development, GlaxoSmithKline in June 2006.

Find out more about Moncef Slaoui

Jean Stéphenne - President and General Manager, Biologicals

Jean Stéphenne was appointed President and General Manager, Biologicals in 1998 and joined the CET in May 2008.

Find out more about Jean Stéphenne

Claire Thomas - Senior Vice President, Human Resources

Claire Thomas was appointed Senior Vice President, Human Resources, in May 2008.

Find out more about Claire Thomas

Dan Troy - Senior Vice President & General Counsel

Dan Troy joined GSK as Senior Vice President and General Counsel in September 2008.

Find out more about Dan Troy

Bob Ingram - Vice Chairman, Pharmaceuticals

Bob Ingram is Vice Chairman Pharmaceuticals, GlaxoSmithKline and a special consultant to the CET and the Group.

Find out more about Bob Ingram

Careers
Interested in joining us?

Visit the Careers section

Quick links

Investors
Annual Report 2007

Download (PDF 1.5Mb)

Downloads

All downloadable images within this section are stored in a compressed format.
You may require the following shareware utilities to expand the files.